Here, the main implications of our findings in how AuPEI can reshape the MET-1 tumor microenvironment are that it can potentially prime tumors for a checkpoint inhibitor (anti-PD-1 or anti-PD-L1 antibody) treatment, enhancing the therapeutic efficacy of the immunotherapy. The gene discussed is CD274; the disease is neoplasm.